Triple Helix Discovery Engine
Triple Helix Framework
Industry
Architects: Small & Medium Size Business (SMBs), Product Development, De-Risking, Validation, Building Niche & Emerging Markets
*Architects: Drug Delivery
Alcyone LifeSciences

Organization & Developments: Alcyone

Parents

Alcyone announced a collaboration with DNAtrix to investigate potential use of Alcyone’s microcatheter system for delivering DNAtrix’s anti-cancer agents directly to brain tumors.
Build on a Drug Delivery Modality Called Convection-enhanced Delivery, where a Fine Needle or Cannula Is Inserted into the Brain through a Small Hole in the Skull
Devices can be smaller than standard needles and designed to avoid challenges with traditional CED infusion therapy, like backflow and plugging.
Neurological disorders are hard to treat for a few reasons, one being the existence of the blood-brain barrier, which blocks potentially damaging toxins from the brain but also keeps out small- and large-molecule drugs.
Target applications for the devices include delivery of drugs for brain cancers, hydrocephalus (often called “water on the brain”) and Huntington’s and Parkinson’s diseases.
The company is also developing technology to manage cerebrospinal fluid shunt occlusions.
They could also have the ability to deliver multiple therapeutic fluids in programmed sequences.